Parasitic infections lead to significant morbidity and mortality, especially in tropical regions. The renal damage caused by these infections occurs via various mechanisms. Two forms of parasitic echinococcus infection widely responsible for infection in humans are Echinococcus granulosus and Echinococcus multilocularis. E. multilocularis causes Alveolar echinococcus infection in humans. Alveolar echinococcus has high mortality, and the possible limits of surgery are generally exceeded by the time of diagnosis. The literature contains no case reports of comorbidity of alveolar echinococcus and glomerulonephritis. Here we discuss the treatment of a patient with comorbid mesangioproliferative glomerulonephritis and alveolar echinococcus, behaving like a tumor, using albendazole since there was no possibility of surgery. This is the first ever such case report.
Introduction
Parasitic infections lead to significant morbidity and mortality, especially in tropical regions. Various renal diseases may develop during the course of such parasitic infections as malaria, schistosomiasis, filiariasis and echinococcus infections (1) . The nephropathy caused by these infections may appear as severe infection systemic effect-dependent involvement, direct invasion of kidney tissue by the parasite and immune interaction between the host and parasite (2) .
Human echinococcus infection is a zoonosis caused by the larval form of Echinococcus (worms inhabiting the intestines of carnivores). Two of the described species that lead to significant disease in humans are Echinococcus granulosus and Echinococcus multilocularis. These give rise to cystic echinococcosis and alveolar echinococcosis, respectively, in humans.
There are many case reports concerning kidney diseases developing during the course of E. granulosus infection. These reports generally involve the parasite directly invading the kidney tissue and glomerulonephritis that is thought to be immune complex-associated (2-4). We encountered no case reports of glomerulonephritis caused by alveolar echinococcus, which is less common than E. granulosus in the literature. Our intention in this report was to describe the first case of glomerulonephritis comorbid with E. alveolaris infection, which can be regarded as a kind of tumoral formation, and to show that albendazole was effective in the treatment of this patient with no possibility of surgery. 
Case Report
A 23-year-old man had been suffering symptoms of nausea, vomiting and lethargy for 20 days. At presentation to our hospital department his blood pressure was 120/80 mmHg, heart rate 84/min and fever 36 , oral mucosa was dry while cardiovascular and respiratory examinations were normal. On abdominal examination the liver was 3 cm palpable with an irregular contour. Peripheral edema was -/-. Skin turgor tone was reduced. Laboratory tests showed hemoglobin 11.4 g/dL, leukocyte number 7,100/μL, platelet count 211,000/μL, BUN 40 mg/dL, creatinine 2.5 mg/dL, Na 138m mol/L, K 4.7 mmol/L, uric acid 7.6 mg/dL, total protein 7.6 g/dL, albumin 3.5 g/dL, LDL 106 mg/dL, HDL 45 mg/dL, triglyceride 95 mg/dL, total cholesterol 166 mg/ dL, density of urine test 1,020 and protein 300 mg/dL. Six percent eosinophilia was determined in peripheral blood. For 24-hour urine we determined 3.08 g/day protein and 1.9 g/ day albumin excretion. No cellular element or cast was determined in urine sediment. ANA (-), Anti Ds DNA(-), C3 and C4 were normal. The patient appeared dehydrated and was started on 3 L/day intravenous hydration. Over the next 2 days BUN decreased to 16 mg/dL and creatinine 1.3 mg/ dL. On abdominal ultrasound, kidney dimensions and parenchymal thickness were normal, while total liver vertical length was 155 mm and a slightly hyperechoic relatively homogeneous mass lesion of 11×11 cm was seen in the right lobe. Dynamic CT directed toward the mass lesion in the liver was planned. Once creatinine had decreased to 1.3 mg/ dL abdominal tomography was performed, accompanied by i.v. hydration and N-acetyl cysteine. Abdominal tomography was compatible with alveolar echinococcus (Fig. 1) . The lesion in the liver was compatible with E. alveolaris; it displaced the main portal vein posteriorly, surrounded the right portal vein and lateral part of the vena cava inferior, and caused dilatation in the right lobe intrahepatic bile ducts.
Cranial and thoracic tomography were normal. Echinococcus Ig G IFA test performed for the diagnosis of the hydatid nature of the cyst was determined at 1/3,200. In the light of the abdominal tomography findings we considered there was no chance of surgery because of the lesion's invasion of the vascular structures. The patient was started on albendazole at 2×400 mg/day. Two days later renal biopsy was performed due to hypoalbuminemia and 3.08 g/day proteinuria. Eight glomeruli were determined at renal biopsy of the patient and all had diffuse global mesangial cellular and matrix increase. Adhesion to Bowman's space and glomerulomegaly was determined in 4-5 glomeruli. The patient had no specific interstitial pathology and amyloid (Congo red) staining was negative. At immunofluorescent staining Ig G, A, M, fibrin, C3, C1q, kappa and lambda staining were negative. Findings were compatible with mesangioproliferative glomerulonephritis (Fig. 2a, b) . On the basis of the current data we ascribed the glomerulonephritis to E. alveolaris infection. At the 1-month check-up of albendazole treatment, nausea, vomiting and lethargy had resolved. Biochemical tests were BUN 19 mg/dL, creatinine 1.4 mg/dL, total protein 8.5 mg/dL, albumin 4.3 mg/dL and 24-hour urine protein excretion 2.2 g/day, while albumin excretion had declined to 1.4 g/day. Hepatic enzymes were normal. Followup was maintained with albendazole treatment and monthly controls.
Discussion
Human E. alveolaris is endemic in 42 countries in the world. In Turkey it is endemic in eastern regions in particular (2, 5) . Alveolar echinococcus is a potentially fatal disease. Diagnosis is made based on the presence of two of the following criteria; typical organ involvement using imaging techniques, echinococcus-specific antibodies in the blood, E. multilocularis metacestodes being identified histopathologically and E. multilocularis nucleic acid being observed in tissue samples (5, 6) . We diagnosed E. alveolaris in the present patient on the basis of the typical alveolar echinococcosis lesions that we determined at liver ultrasonography and tomography and serological test positivity.
Surgical resection is the main method of treatment recommended for E. alveolaris (6) . However, in the present case because of the invasion of the portal vein and vascular structures no surgical or interventional radiological technique could be performed. For that reason, our patient was treated in clinical follow-up with albendazole (daily dosage of 800 mg in adults), as recommended in the medical treatment of E. alveolaris.
As in other parasitic infections, renal involvement in echinococcus infections takes place through the three mechanisms cited above. Hydatid cyst formation is seen in 2-3% of echinococcus patients (1) . Immune-mediated glomerulonephritis, another renal involvement mechanism, has been reported to accompany E. granulosus infection. These case reports took the form of membranous nephropathy (7), me- sangiocapillary glomerulopathy (3, 4) and minimal change disease (8) . There also exists a case report of E. granulosus infection, a chronic inflammatory process, and amyloidosis (9) . In these cases, the removal of the tissue in which the parasite was present generally led to improvement of the glomerular damage. However, we encountered no case report of E. alveolaris, which is more fatal than E. granulosus, accompanied by glomerulonephritis. The kidney biopsy in the present case was compatible with mesangioproliferative glomerulonephritis.
Pathologically, mesangioproliferative glomerulonephritis is a form of glomerulonephritis with cellular and/or matrix increase in the glomerular mesangium. The most commonly seen form is Ig A nephropathy (10) . Mesangioproliferative glomerulonephritis may develop during the course of parasitic infections (1) . The course of mesangioproliferative glomerulonephritis, with or without immunohistological deposit, is rather good in the presence of glomerulitis alone. However, the prognosis in the presence of interstitial inflammation, fibrosis or acute renal failure is poor (11) . In the present case, we considered immunohistologically negative mesangioproliferative glomerulonephritis because of the increased mesangial cell and matrix among the light microscopy findings and since no deposit was determined at immunofluorescent examination. However, we were unable to completely exclude immune deposit since no electron microscopic investigation was performed. In the light of these findings, the renal pathology in our case was compatible with mesangioproliferative glomerulonephritis with no immune deposit. We thought the etiology was E. alveolaris that we diagnosed radiologically and serologically. The size of the lesion in the liver and the calcifications therein suggested that E. alveolaris infection had been present for a long time. As Bohle et al stated (11) , the absence of interstitial interaction during this process, probably lasting years, may be a marker of good GN prognosis. Considering that glomerulonephritis may retract with treatment of the parasite we first wished to evaluate the possibility of surgical resection, but since surgical line had been exceeded we began parasitic infection treatment and also albendazole for the purpose of treating the glomerulonephritis. At 1-month check-up there was a significant decline in proteinuria and a rise in blood albumin levels.
In conclusion, glomerulonephritis may develop during the course of alveolar echinococcus infection. In addition, the use of albendazole may be beneficial in the treatment of glomerulonephritis in patients with no possibility of surgery.
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